Background
Methods
Study population & research design
Data collection
Outcome parameters
Statistical analysis
Results
Study population
Characteristics | Patients in which the protocol was followed (n = 140) | Patients in which the protocol was not followed (n = 22) | Total (n = 162) | P-value | |
---|---|---|---|---|---|
Male sex [n (%)] | 82 (59) | 11 (50) | 93 (57) | 0.45 | |
Age (years) | 68 ± 13 | 68 ± 12 | 68 ± 13 | 0.78 | |
Prehospital oxygen | Yes [n (%)] | 94 (67) | 18 (82) | 112 (69) | 0.16 |
Within target at arrival* | Yes [n (%)] | 56 (60) | 1 (6) | 57 (51) | 0.00 |
PaO2 (kPa) | 9 (8–12) | 8 (8–11) | 9 (8–12) | 0.53 | |
Systolic blood pressure (mmHg) | 125 (107–141) | 137 (119–165) | 126 (109–145) | 0.04 | |
Diastolic blood pressure (mmHg) | 76 (65–89) | 76 (65–103) | 76 (65–89) | 0.49 | |
Heart rate (beats/min) | 88 (75–108) | 95 (88–120) | 91 (78–110) | 0.06 | |
Respiratory rate (breaths/min) | 21 (18–25) | 22 (20–27) | 21 (18–25) | 0.17 | |
GCS [1–15]** | 15 (15–15) | 15 (15–15) | 15 (15–15) | 0.24 | |
MEWS | 4 (3–5) | 4 (3–6) | 4 (3–5) | 0.27 | |
Smoking [n (%)] | 30 (21) | 8 (36) | 38 (24) | 0.12 | |
Cardiac condition [n (%)] | 57 (41) | 10 (46) | 67 (41) | 0.68 | |
COPD GOLD I/II [n (%)] | 27 (19) | 3 (14) | 30 (19) | 0.53 | |
COPD GOLD III/IV [n (%)] | 14 (10) | 11(50) | 25 (15) | 0.00 | |
Other pulmonary condition [n (%)] | 19 (14) | 5 (23) | 24 (15) | 0.26 | |
Neurological condition [n (%)] | 1 (1) | 1 (5) | 2 (1) | 0.13 |
Diagnosis at discharge
Diagnosis at discharge from ED | Protocol was followed [n (%)] | Protocol was not followed [n (%)] | Total [n (%)] | P-value |
---|---|---|---|---|
Pneumonia | 30 (21) | 4 (18) | 34 (21) | 1.00 |
Infection | 28 (20) | 6 (27) | 34 (21) | 0.41 |
Heart failure | 22 (16) | 4 (18) | 26 (16) | 0.76 |
Other | 23 (16) | 1 (5) | 24 (15) | 0.20 |
Sepsis | 22 (16) | 2 (9) | 24 (15) | 0.54 |
COPD exacerbation | 14 (10) | 8 (36) | 22 (14) | 0.03 |
Cardiac condition other | 17 (12) | 0 (0) | 17 (11) | 0.13 |
Pulmonary condition other | 10 (7) | 5 (23) | 15 (9) | 0.04 |
Malignancy | 11 (8) | 1 (5) | 12 (7) | 1.00 |
Neurological | 6 (4) | 1 (5) | 7 (4) | 1.00 |